OGRMF - OrganiGram Holdings Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.56
+0.31 (+9.51%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.25
Open3.26
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.20 - 3.62
52 Week Range1.67 - 4.60
Volume297,788
Avg. Volume350,015
Market Cap448.61M
Beta5.82
PE Ratio (TTM)N/A
EPS (TTM)-0.03
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group8 days ago

    Organigram Signs Strategic Supplier Agreement with Hiku Brands

    MONCTON, NB , July 10, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, is pleased to announce that it has entered into a letter of intent ("LOI") with Hiku Brands Company Ltd. (CSE:HIKU) ("Hiku").

  • TheStreet.com9 days ago

    Canopy Growth Leads Cannabis Debt Bonanza

    A total of $1.2 billion in debt via 52 transactions was floated by public and private cannabis companies in the six months ended June 29, according to data from Viridian Capital Advisors, the New York-based cannabis-focused advisory and investment banking boutique. , which sold a whopping $460 million in convertible notes in a deal that closed on June 20. A spokesperson for the company did not comment on the company's debt offering, which was handled by Cowen and Co. and BMO Nesbitt Burns as joint bookrunning managers.

  • Interview With a Marijuana CEO: OrganiGram's Greg Engel Answers 6 Pressing Questions
    Motley Fool9 days ago

    Interview With a Marijuana CEO: OrganiGram's Greg Engel Answers 6 Pressing Questions

    OrganiGram's CEO discusses everything from his company's superior crop yield to what percentage of production could derive from dried cannabis alternatives.

  • How Producers Can Use Pricing to Expand Sales
    Market Realist9 days ago

    How Producers Can Use Pricing to Expand Sales

    In the earlier part of this series, we discussed how provincial governments in Canada could take various approaches to selling recreational cannabis to customers after legalization. In provinces where cannabis producers sell directly to a government entity, companies such as Canopy Growth (CGC) (WEED), Aurora Cannabis (ACB), Organigram (OGRMF), and others will have limited access to customers.

  • Better Marijuana Stock: Auxly Cannabis (Formerly Cannabis Wheaton) vs. Organigram Holdings
    Motley Fool12 days ago

    Better Marijuana Stock: Auxly Cannabis (Formerly Cannabis Wheaton) vs. Organigram Holdings

    It's a streaming model going up against a traditional grower in this match-up between two Canadian marijuana stocks.

  • CNW Group13 days ago

    Organigram signs supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC)

    MONCTON, NB, July 5, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading  licensed producer of medical marijuana, is pleased to announce that the Company has signed a supply agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC) in anticipation of the launch of a legal, adult use recreational cannabis market in the Province of Alberta .

  • TheStreet.com14 days ago

    How to Invest in Cannabis - In Its Many Forms

    When states and countries legalize cannabis, new businesses appear out of nowhere. California legalized recreational marijuana at the very beginning of 2018. Within two weeks, two dozen Los Angeles businesses got approval to sell recreational products.

  • CNW Group19 days ago

    Organigram signs supply agreement with Manitoba Liquor & Lotteries

    MONCTON, NB , June 29, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that it has been approved as a supplier of cannabis for the province of Manitoba . "We are proud to work with MBLL to offer residents of Manitoba a choice of high-quality cannabis products," says Tim Emberg , Organigram Vice President of Sales and Commercial Operations.

  • 3 Marijuana Stocks to Consider Buying Right Now
    Motley Fool23 days ago

    3 Marijuana Stocks to Consider Buying Right Now

    These pot stocks could have investors seeing green.

  • GlobeNewswirelast month

    Acology Announces Big LP Order; Canadian Market Begins to Move

    Acology Inc. (ACOL) announced today that Organigram Holdings Inc. (OGRMF) has renewed another order for Acology’s signature product, the MedTainer™, which will be custom printed for the Canadian LP and equipped with Acology’s MedX 2-way humidity packs. Acology, having completed and submitted applications to each Canadian provincial authority delegated to adopt and enforce packaging compliance, is now finalizing steps in several provinces to serve as a primary retail package for legal cannabis in those provinces. There will be a refractive period of at least 14 weeks before the Canadian market can be fully operational, as there are several legislative hurdles still to jump and Ottawa cautiously moves to full licensing and operation.

  • Better Marijuana Stock: CannTrust Holdings vs. Organigram Holdings
    Motley Foollast month

    Better Marijuana Stock: CannTrust Holdings vs. Organigram Holdings

    Which Canadian marijuana stock wins in a head-to-head matchup?

  • This Marijuana Value Stock Just Got a Little Bigger
    Motley Foollast month

    This Marijuana Value Stock Just Got a Little Bigger

    More cannabidiol oil production? Yes, please!

  • CNW Grouplast month

    Orgranigram applauds Senate vote in support of Bill C-45

    MONCTON, NB , June 8, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased that Bill C-45 has been passed by the Senate in a historic vote, clearing another key milestone on the way to the legalization of adult-use recreational cannabis in Canada . "As a company, we are pleased to see Bill C-45 continue to make its way through the regulatory process," says Greg Engel , CEO, Organigram.

  • CNW Grouplast month

    Organigram Announces Health Canada Licensing of Phase 3 Cultivation Expansion

    TORONTO , June 5, 2018 /CNW/ - Organigram Holdings Inc. ("Organigram" or the "Company") (TSX VENTURE: OGI) (OGRMF) a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that it has received an expanded cultivation license from Health Canada related to its previously announced Phase 3 expansion. The remaining ten Phase 3 rooms are expected to come online on or before June 30, 2018 in stages pending Health Canada approval.

  • FSCWirelast month

    Organigram Enters into Non-Binding Term Sheet for 26% Equity Interest in Eviana Health Corporation

    Organigram Holdings Inc. (“Organigram”) (TSX VENTURE: OGI) (OTCQB: OGRMF) and Eviana Health Corporation (“Eviana”) (CSE: EHC) (OTC: EVNNF) (collectively the “Companies”) are pleased to jointly announce that the Companies have entered into a non-binding term sheet (the “Term Sheet”) whereby Organigram will make a significant equity investment into Eviana.  Additionally, the Term Sheet contemplates Organigram entering into an offtake agreement with Eviana for up to 50% of the cannabidiol (“CBD”) production of Eviana for a period of five years, subject to adjustment based on Organigram’s equity interest in Eviana. “This agreement is a key facet of our ongoing international expansion efforts,” explains Greg Engel, CEO, Organigram.

  • ACCESSWIRE2 months ago

    Organigram Holdings Shares Climb as Canada Cannabis Legalization Draws Near

    NEW YORK, NY / ACCESSWIRE / May 31, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is initiating coverage on Organigram Holdings, Inc. (OGRMF), a company who through its wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and Organigram is regulated by the Access to Cannabis for Medical Purposes Regulations.

  • Move Over, OrganiGram, There's a New Marijuana Value Stock in Town
    Motley Fool2 months ago

    Move Over, OrganiGram, There's a New Marijuana Value Stock in Town

    Despite strong sales growth expected in 2018 and 2019, this pot stock is valued at just 24 times Wall Street's consensus EPS for next year.

  • Benzinga2 months ago

    4 Potential Takeout Candidates In The Marijuana Sector

    A consolidation wave is sweeping across the marijuana industry, as companies aim to improve their competitive positioning and market share in an industry which offers a lot a promise. Aurora Cannabis Inc (OTC: ACBFF) recently announced a deal to buy MedReleaf Corp (OTC: MEDFF) in an all-cash transaction valued at C$3.2 billion. The proposed combination would mean a total funded capacity of over 570,000 kg per year of high-quality facilities in Canada and Denmark.

  • 3 Marijuana Stocks That Could Be Gobbled Up Next
    Motley Fool2 months ago

    3 Marijuana Stocks That Could Be Gobbled Up Next

    More marijuana acquisitions could be on the way. And these three stocks rank high on the list of buyout candidates.

  • CNW Group2 months ago

    Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.

    MONCTON, NB , May 24, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF) ("Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that it has entered into a letter of intent with Hyasynth Biologicals, Inc. ("Hyasynth") whereby Organigram proposes to make a strategic investment in Hyasynth.  Additionally, the non-binding letter of intent contemplates Organigram entering into an off-take agreement with Hyasynth whereby Organigram can purchase a pre-defined quantity of a range of cannabinoids or cannabinoid related production from Hyasynth on terms set forth in such agreement.

  • CNW Group2 months ago

    Organigram Receives Permit to Export Medical Cannabis to Australia

    Organigram Receives Permit to Export Medical Cannabis to Australia

  • CNW Group2 months ago

    Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada

    MONCTON, NB , May 15, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce that Health Canada has issued the Company a License for Controlled Drugs and Substances ("Dealer's License") making Organigram a "Licensed Dealer".

  • Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
    CNW Group2 months ago

    Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands

    Organigram's unprecedented recreational portfolio will be officially launched once adult use recreational cannabis is legal in Canada and includes the launch of The Edison Cannabis Company, ANKR Organics and Trailer Park Buds.

  • CNW Group2 months ago

    Organigram Announces First International Expansion Investment

    MONCTON, NB , May 8, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE: OGI) (OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick , is pleased to announce it has entered a non-binding term sheet to acquire up to 25 per cent of alpha-cannabis Pharma GmbH ("Alpha-Cannabis Germany" or "ACG") located in Stadthagen, Germany .

  • A Grim Reality for Marijuana Stock Investors
    Motley Fool3 months ago

    A Grim Reality for Marijuana Stock Investors

    Pot stocks may not generate as much green as expected.